FR2348207A1 - Derive a liaison peptidique utilisable en medecine humaine et son procede de preparation - Google Patents

Derive a liaison peptidique utilisable en medecine humaine et son procede de preparation

Info

Publication number
FR2348207A1
FR2348207A1 FR7711801A FR7711801A FR2348207A1 FR 2348207 A1 FR2348207 A1 FR 2348207A1 FR 7711801 A FR7711801 A FR 7711801A FR 7711801 A FR7711801 A FR 7711801A FR 2348207 A1 FR2348207 A1 FR 2348207A1
Authority
FR
France
Prior art keywords
derivative
preparation process
human medicine
link used
peptidic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7711801A
Other languages
English (en)
French (fr)
Other versions
FR2348207B1 (cg-RX-API-DMAC7.html
Inventor
Jorge Iniesta Pons
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Investigacion Tecnica y Aplicada SA
Original Assignee
Investigacion Tecnica y Aplicada SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Investigacion Tecnica y Aplicada SA filed Critical Investigacion Tecnica y Aplicada SA
Publication of FR2348207A1 publication Critical patent/FR2348207A1/fr
Application granted granted Critical
Publication of FR2348207B1 publication Critical patent/FR2348207B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
FR7711801A 1976-04-15 1977-04-14 Derive a liaison peptidique utilisable en medecine humaine et son procede de preparation Granted FR2348207A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES447114A ES447114A1 (es) 1976-04-15 1976-04-15 Nuevo procedimiento para la preparacion de derivados con en-lace peptidico.

Publications (2)

Publication Number Publication Date
FR2348207A1 true FR2348207A1 (fr) 1977-11-10
FR2348207B1 FR2348207B1 (cg-RX-API-DMAC7.html) 1980-02-08

Family

ID=8471384

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7711801A Granted FR2348207A1 (fr) 1976-04-15 1977-04-14 Derive a liaison peptidique utilisable en medecine humaine et son procede de preparation

Country Status (5)

Country Link
JP (1) JPS52128383A (cg-RX-API-DMAC7.html)
DE (1) DE2716374C2 (cg-RX-API-DMAC7.html)
ES (1) ES447114A1 (cg-RX-API-DMAC7.html)
FR (1) FR2348207A1 (cg-RX-API-DMAC7.html)
GB (1) GB1535683A (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0007648A1 (en) * 1978-08-02 1980-02-06 Investigacion Tecnica Y Aplicada, S.A. New acylureas with pharmaceutical activity, the process for their preparation, and pharmaceutical compositions which contain them

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2052014A1 (en) * 1990-10-19 1992-04-20 Henry Y. Pan Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1296513B (de) * 1965-12-30 1969-05-29 Adox Du Pont Fotowerke Verfahren zum Haerten von gelatinehaltigen photographischen Schichten, insbesondere Halogensilberemulsionsschichten
US3927092A (en) * 1968-06-24 1975-12-16 Merck & Co Inc Amides of 2-{8 halophenoxy (or halophenylthio){9 -alkanoic acids
DE1936282A1 (de) * 1969-07-17 1971-01-28 Ruhrchemie Ag Verfahren zur Herstellung von N,N'-disubstituierten Harnstoffen und Thioharnstoffen
FR2187311B1 (cg-RX-API-DMAC7.html) * 1972-06-02 1975-06-20 Bouchara Emile

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0007648A1 (en) * 1978-08-02 1980-02-06 Investigacion Tecnica Y Aplicada, S.A. New acylureas with pharmaceutical activity, the process for their preparation, and pharmaceutical compositions which contain them

Also Published As

Publication number Publication date
DE2716374C2 (de) 1986-09-25
FR2348207B1 (cg-RX-API-DMAC7.html) 1980-02-08
GB1535683A (en) 1978-12-13
DE2716374A1 (de) 1977-11-03
ES447114A1 (es) 1977-11-01
JPS52128383A (en) 1977-10-27

Similar Documents

Publication Publication Date Title
BE857931A (fr) Gel de phospha-alumine et son procede de preparation
BE850401A (fr) Derives de phtalane et procede de preparation
IT7821872A0 (it) Derivati d'acetammide impiegabili segnatamente in terapia, eprocedimento per produrli.
FR2339624A1 (fr) Pullulane reticule et son procede de preparation
FR2393795B1 (fr) Derives de carbostyryle, leur procede de preparation et leurs applications en therapeutique
BE855357A (fr) Nouveau medicament immunostimulant et son procede de preparation
DE2861089D1 (en) Dihydropyridazones, their preparation and medicines containing them and dihydropyridazones for use in medical treatments
FR2274376A1 (fr) Procede et dispositif de rivetage rapide
BE854268A (fr) Pyrrolidones, leur procede de preparation et leur application therapeutique
AU508150B2 (en) Decolorized blood and food products thereof
BE862785A (fr) Derives de pyrimido(6,1-a)isoquinoleine-2-one, leur procede de preparation et leur application en therapeutique
FR2634974B1 (fr) Emulsion transparente insecticide et son procede de preparation
FR2348907A1 (fr) Derives polyprenyliques,leur procede de preparation et leur application en therapeutique
FR2301598A1 (fr) Procede et dispositif de patentage associe a un processus d'etirage
DE2860858D1 (en) Indolacetoxyacetylaminoacid derivatives, process for their preparation and their use in drugs
BE853604A (fr) Vaccin antirabique et son procede de preparation
LU77557A1 (fr) Nouveau 2-deoxystreptamine-aminoglycoside,son procede de preparation et medicament le contenant
BE868068A (fr) Inhibiteurs du complement, leur procede de preparation et leur utilisation en medecine humaine et veterinaire
BE866383A (fr) Nouveau polymere et son procede de preparation
PT65124B (fr) Lucknomycine et son procede de preparation
BE868114A (fr) Mercaptoacetylamidobenzoylglycine et procede therapeutique de mucolyse
FR2348207A1 (fr) Derive a liaison peptidique utilisable en medecine humaine et son procede de preparation
DE2860981D1 (en) 4-hydroxy-2-benzimidazolinone derivatives, process for their preparation and their use in medicaments
FR2349587A1 (fr) 1,3-dihydro-heteroarylspiro(isobenzofurannes), leur procede de preparation et leur application therapeutique
BE880615A (fr) Nouveau derive du paracetamol, son procede de preparation et son utilisation en therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse